Vimarsana
Biggest News Aggregation in the World

Page 2 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

Medtronic's Inceptiv closed-loop spinal cord stimulator earns FDA approval - Vimarsana News

Medtronic's Inceptiv closed-loop spinal cord stimulator earns FDA approval

Medtronic earned FDA approval for its Inceptiv closed-loop spinal cord stimulator, the company said April 26.

What We're Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall - Vimarsana News

What We're Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall

The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.

Source: ajmc.com
8 spine, orthopedic robotics updates in 60 days - Vimarsana News

8 spine, orthopedic robotics updates in 60 days

Discover the latest updates in spine and orthopedic robotics, including surgeon milestones, FDA approvals, and new robot additions at top medical centers.

Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol - Vimarsana News

Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol

/PRNewswire/ -- More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat...

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection - Vimarsana News

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...